Are Sigma Receptor Modulators a Weapon Against Multiple Sclerosis Disease?
- 27 October 2017
- journal article
- Published by Taylor & Francis in Future Medicinal Chemistry
- Vol. 9 (17) , 2029-2051
Abstract
Effective therapies for multiple sclerosis (MS) are still missing. This neurological disease affects more than 2.5 million people worldwide. To date, biological immunomodulatory drugs are effective and safe during short-term treatment, but they are suitable only for parenteral administration and they are expensive. Accordingly, academic and industrial environments are still focusing their efforts toward the development of new MS drugs. Considering that neurodegeneration is a contributory factor in the onset of MS, herein we will focus on the crucial role played by sigma 1 receptors (S1Rs) in MS. A pilot study was performed, evaluating the effect of the S1R agonist (R)-RC33 on rat dorsal root ganglia experimental model. The encouraging results support the potential of S1R agonists for MS treatment.Keywords
This publication has 160 references indexed in Scilit:
- Synaptic plasticity of NMDA receptors: mechanisms and functional implicationsCurrent Opinion in Neurobiology, 2012
- The sigma-1 receptor protects against cellular oxidative stress and activates antioxidant response elementsEuropean Journal of Pharmacology, 2012
- Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signalingCellular Signalling, 2012
- Sigma Receptor Agonists: Receptor Binding and Effects on Mesolimbic Dopamine Neurotransmission Assessed by MicrodialysisBiological Psychiatry, 2011
- The sigma-1 receptor is enriched in postsynaptic sites of C-terminals in mouse motoneurons. An anatomical and behavioral studyNeuroscience, 2010
- Sigma receptor ligand 4-phenyl-1-(4-phenylbutyl)-piperidine modulates neuronal nitric oxide synthase/postsynaptic density-95 coupling mechanisms and protects against neonatal ischemic degeneration of striatal neuronsExperimental Neurology, 2010
- The pharmacology of sigma-1 receptorsPharmacology & Therapeutics, 2009
- MAM: more than just a housekeeperTrends in Cell Biology, 2009
- Sigma receptors suppress multiple aspects of microglial activationGlia, 2008
- Multiple sclerosisThe Lancet, 2008